Role of Ayurveda Herbo-mineral (with gold) tablets in Myoclonic Epilepsy in children

A clinical study on Aurokid Plus tablet as adjuvant therapy in the management of pediatric Myoclonic Epilepsy - A proof of concept - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065579

Enrollment

Registered

2024-04-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G40B- Juvenile myoclonic epilepsy [impulsive petit mal]

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Childhood ME and its type Prediagnosed cases minimum chronicity 6 months and less than 5 years

Exclusion criteria

Exclusion criteria: Acute and Chronic systemic diseases episodes of 2 or more status epilepticus in last 6 months

Design outcomes

Primary

Measure	Time frame
Improvement on Cognition on the basis of Binnet Kamat Scale and MMASTimepoint: day 30 and day 60	—

Secondary

Measure	Time frame
Improvement in Quality of life on basis WHO QoL Questioner 55Timepoint: day 30 & day 60	—

Countries

India

Contacts

Public ContactDR SWAPNIL CR

Parul Institute of Ayurved

neonatecare97@gmail.com9726587013

Outcome results